These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 34708452)
41. Functional expression and pharmaceutical efficacy of cardiac-specific ion channels in human embryonic stem cell-derived cardiomyocytes. Kim HS; Yoon JW; Li H; Jeong GO; Park JJ; Shin SE; Jang IH; Kim JH; Park WS Sci Rep; 2017 Oct; 7(1):13821. PubMed ID: 29062050 [TBL] [Abstract][Full Text] [Related]
42. Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro--correlation between contraction force and electrophysiology. Ribeiro MC; Tertoolen LG; Guadix JA; Bellin M; Kosmidis G; D'Aniello C; Monshouwer-Kloots J; Goumans MJ; Wang YL; Feinberg AW; Mummery CL; Passier R Biomaterials; 2015 May; 51():138-150. PubMed ID: 25771005 [TBL] [Abstract][Full Text] [Related]
43. Chemically defined generation of human cardiomyocytes. Burridge PW; Matsa E; Shukla P; Lin ZC; Churko JM; Ebert AD; Lan F; Diecke S; Huber B; Mordwinkin NM; Plews JR; Abilez OJ; Cui B; Gold JD; Wu JC Nat Methods; 2014 Aug; 11(8):855-60. PubMed ID: 24930130 [TBL] [Abstract][Full Text] [Related]
44. Cardiomyocyte Differentiation from Human Embryonic Stem Cells. Mazzotta S; Lynch AT; Hoppler S Methods Mol Biol; 2018; 1816():67-78. PubMed ID: 29987811 [TBL] [Abstract][Full Text] [Related]
45. Video image-based analysis of single human induced pluripotent stem cell derived cardiomyocyte beating dynamics using digital image correlation. Ahola A; Kiviaho AL; Larsson K; Honkanen M; Aalto-Setälä K; Hyttinen J Biomed Eng Online; 2014 Apr; 13():39. PubMed ID: 24708714 [TBL] [Abstract][Full Text] [Related]
46. Generation, characterization, and potential therapeutic applications of cardiomyocytes from various stem cells. Liu J; Zhang Z; Liu Y; Guo C; Gong Y; Yang S; Ma M; Li Z; Gao WQ; He Z Stem Cells Dev; 2012 Aug; 21(12):2095-110. PubMed ID: 22428725 [TBL] [Abstract][Full Text] [Related]
47. Automated Dynamic Clamp for Simulation of I Becker N; Horváth A; De Boer T; Fabbri A; Grad C; Fertig N; George M; Obergrussberger A Curr Protoc Pharmacol; 2020 Mar; 88(1):e70. PubMed ID: 31868992 [TBL] [Abstract][Full Text] [Related]
49. [Guidance of instructions for compiling expert consensus on clinical practice of Chinese patent medicine of China Association of Chinese Medicine]. Mo M; Zhang XX; Liao X; Li B; Chen W; Zhao GZ; Guo YB Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2652-2656. PubMed ID: 31359736 [TBL] [Abstract][Full Text] [Related]
50. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system. Kolanowski TJ; Busek M; Schubert M; Dmitrieva A; Binnewerg B; Pöche J; Fisher K; Schmieder F; Grünzner S; Hansen S; Richter A; El-Armouche A; Sonntag F; Guan K Acta Biomater; 2020 Jan; 102():273-286. PubMed ID: 31778832 [TBL] [Abstract][Full Text] [Related]
51. Effective Hypothermic Storage of Human Pluripotent Stem Cell-Derived Cardiomyocytes Compatible With Global Distribution of Cells for Clinical Applications and Toxicology Testing. Correia C; Koshkin A; Carido M; Espinha N; Šarić T; Lima PA; Serra M; Alves PM Stem Cells Transl Med; 2016 May; 5(5):658-69. PubMed ID: 27025693 [TBL] [Abstract][Full Text] [Related]
52. [From precursor to reprogrammed cells: evolution of cardiomyoplasty]. Szala S; Matuszczak S; Czapla J; Wiśniewska E Postepy Hig Med Dosw (Online); 2014 Feb; 68():153-61. PubMed ID: 24491907 [TBL] [Abstract][Full Text] [Related]
53. Optimizing the Differentiation of Cardiomyocytes from Human Induced Pluripotent-Derived Stem Cells. Gartz M; Strande JL Methods Mol Biol; 2021; 2319():51-60. PubMed ID: 34331242 [TBL] [Abstract][Full Text] [Related]
54. Heart Regeneration by Endogenous Stem Cells and Cardiomyocyte Proliferation: Controversy, Fallacy, and Progress. He L; Nguyen NB; Ardehali R; Zhou B Circulation; 2020 Jul; 142(3):275-291. PubMed ID: 32687441 [TBL] [Abstract][Full Text] [Related]
55. Cardiomyocyte death and renewal in the normal and diseased heart. Buja LM; Vela D Cardiovasc Pathol; 2008; 17(6):349-74. PubMed ID: 18402842 [TBL] [Abstract][Full Text] [Related]
56. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes. van den Heuvel NH; van Veen TA; Lim B; Jonsson MK J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890 [TBL] [Abstract][Full Text] [Related]
57. Cardiomyocyte culture - an update on the in vitro cardiovascular model and future challenges. Parameswaran S; Kumar S; Verma RS; Sharma RK Can J Physiol Pharmacol; 2013 Dec; 91(12):985-98. PubMed ID: 24289068 [TBL] [Abstract][Full Text] [Related]
58. Purification of Pluripotent Stem Cell-Derived Cardiomyocytes Using CRISPR/Cas9-Mediated Integration of Fluorescent Reporters. Galdos FX; Darsha AK; Paige SL; Wu SM Methods Mol Biol; 2021; 2158():223-240. PubMed ID: 32857377 [TBL] [Abstract][Full Text] [Related]
59. Non-coding RNAs in Cardiac Regeneration. van der Ven CFT; Hogewoning BCR; van Mil A; Sluijter JPG Adv Exp Med Biol; 2020; 1229():163-180. PubMed ID: 32285411 [TBL] [Abstract][Full Text] [Related]
60. Concise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease. van Meer BJ; Tertoolen LG; Mummery CL Stem Cells; 2016 Aug; 34(8):2008-15. PubMed ID: 27250776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]